Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit

See Release

2022 News

Archives

Endologix Receives FDA Approval of PMA Supplement for AFX2 System

Endologix Announces 12-Month Results of DETOUR-2 Trial at 2022 VIVA Late-Breaking Clinical Trial Session

Endologix Reports Five-Year Data of the LEOPARD Trial at 2022 Vascular InterVentional Advances (VIVA) Conference

ELEVATE IDE Study highlights the Safety and Effectiveness of the ALTO® Abdominal Stent Graft System in One-year Results; Data to Be Presented at 2022 VEITHsymposium

Endologix Submits Premarket Approval (PMA) Application to FDA for the DETOUR™ System.